Free Trial

Avalo Therapeutics (AVTX) Institutional Ownership

Avalo Therapeutics logo
$12.96
-0.04 (-0.31%)
(As of 11/1/2024 ET)

Institutional Ownership Changes (13F Filings) for Avalo Therapeutics (NASDAQ:AVTX)

Current
Institutional Ownership
Percentage
87.06%
Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$16.60M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$45.50K
Get AVTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avalo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

AVTX Institutional Buying and Selling by Quarter

Avalo Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/27/2024Logos Global Management LP539,079$6.72M0.5%N/A52.135%
8/15/2024Affinity Asset Advisors LLC45,000$561K0.1%+350.0%4.352%
5/17/2024Ikarian Capital LLC46,648$1.02M0.1%N/A4.511%
5/15/2024Affinity Asset Advisors LLC10,000$218K0.0%N/A0.971%
5/14/2024Natixis2,512$55K0.0%-45.4%0.244%
11/13/2023Acadian Asset Management LLC283,306$34K0.0%N/A1.399%
8/11/2023VR Adviser LLC1,250,000$444K0.1%+25.0%6.173%
5/16/2023Great Point Partners LLC474,639$831K0.2%N/A3.595%
5/5/2023Monashee Investment Management LLC60,000$105K0.0%N/A0.455%
2/15/2023Nantahala Capital Management LLC540,667$2.73M0.2%-1.3%5.746%
11/14/2022Armistice Capital LLC3,964,666$13.16M0.2%-91.7%42.115%
11/14/2022Point72 Asset Management L.P.500,737$1.66M0.0%-91.7%5.319%
11/10/2022Nantahala Capital Management LLC547,814$1.82M0.1%-91.8%5.819%
10/27/2022 Assenagon Asset Management S.A.15,646$52K0.0%N/A0.166%
8/15/2022Nantahala Capital Management LLC6,710,327$3.36M0.2%-2.0%71.280%
8/15/2022Opaleye Management Inc.450,000$225K0.1%-69.1%4.780%
5/12/2022Integral Health Asset Management LLC700,000$507K0.1%-56.9%0.621%
5/3/2022Leo Brokerage LLC62,629$45K0.0%N/A0.056%
4/25/2022 Assenagon Asset Management S.A.42,338$31K0.0%-92.7%0.038%
2/15/2022Stonepine Capital Management LLC1,510,095$2.57M1.2%+77.7%1.344%
2/15/2022LGL Partners LLC28,850$49K0.0%N/A0.026%
2/14/2022Freestone Capital Holdings LLC20,000$34K0.0%N/A0.018%
2/14/2022Soleus Capital Management L.P.770,000$1.31M0.1%N/A0.686%
2/8/2022Northern Trust Corp533,578$907K0.0%+3.1%0.475%
2/1/2022 Assenagon Asset Management S.A.582,718$991K0.0%-33.7%0.519%
1/24/2022Strs Ohio38,400$65K0.0%-40.2%0.034%
1/20/2022Minot Wealth Management LLC34,645$59K0.0%-66.5%0.031%
12/29/2021Hudson Bay Capital Management LP197,133$430K0.0%N/A0.176%
11/16/2021Opaleye Management Inc.1,459,400$3.18M0.6%N/A1.299%
11/16/2021Squarepoint Ops LLC18,657$41K0.0%N/A0.017%
11/16/2021Two Sigma Advisers LP801,300$1.75M0.0%N/A0.713%
11/16/2021Two Sigma Investments LP732,931$1.60M0.0%N/A0.653%
11/16/2021Laurion Capital Management LP330,444$720K0.0%N/A0.294%
11/15/2021Point72 Asset Management L.P.6,008,850$13.10M0.1%N/A5.350%
11/15/2021Atom Investors LP27,507$60K0.0%N/A0.024%
11/15/2021Voya Investment Management LLC21,854$48K0.0%N/A0.019%
11/15/2021 Caas Capital Management LP11,812$26K0.0%N/A0.011%
11/12/2021Aristides Capital LLC48,953$107K0.0%N/A0.044%
11/12/2021Stonepine Capital Management LLC850,000$1.85M0.8%N/A0.770%
11/12/2021Geode Capital Management LLC1,242,382$2.71M0.0%N/A1.126%
True paradigm shift (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

11/12/2021Integral Health Asset Management LLC1,625,000$3.54M1.0%N/A1.473%
11/10/2021Goldman Sachs Group Inc.672,664$1.47M0.0%N/A0.610%
11/10/2021 Creative Planning14,814$32K0.0%N/A0.013%
11/10/2021Alliancebernstein L.P.19,100$42K0.0%N/A0.017%
11/9/2021BlackRock Inc.3,716,943$8.10M0.0%N/A3.369%
11/9/2021Monashee Investment Management LLC270,000$589K0.1%N/A0.245%
11/8/2021Meeder Asset Management Inc.19,260$43K0.0%N/A0.017%
11/4/2021Asymmetry Capital Management L.P.534,621$1.17M0.7%N/A0.485%
11/4/2021Deutsche Bank AG31,794$69K0.0%N/A0.029%
11/2/2021 Cambridge Investment Research Advisors Inc.12,164$27K0.0%N/A0.011%
11/2/2021 New York State Common Retirement Fund22,214$48K0.0%N/A0.020%
11/2/2021Victory Capital Management Inc.15,788$34K0.0%N/A0.014%
11/1/2021 SG Americas Securities LLC18,596$41K0.0%N/A0.017%
10/29/2021Commonwealth Equity Services LLC52,000$113K0.0%N/A0.047%
10/25/2021Minot Wealth Management LLC103,410$225K0.0%N/A0.094%
10/22/2021Strs Ohio64,200$139K0.0%N/A0.058%
10/19/2021 Assenagon Asset Management S.A.879,334$1.92M0.0%N/A0.797%
10/19/2021 Tamar Securities LLC23,084$50K0.0%N/A0.021%
(Data available from 1/1/2016 forward)

AVTX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AVTX shares?

During the previous two years, 11 institutional investors and hedge funds held shares of Avalo Therapeutics. The most heavily invested institutionals were Armistice Capital LLC ($13.16M), Logos Global Management LP ($6.72M), Nantahala Capital Management LLC ($2.73M), Point72 Asset Management L.P. ($1.66M), Ikarian Capital LLC ($1.02M), Great Point Partners LLC ($831K), and Affinity Asset Advisors LLC ($561K).Learn more on AVTX's institutional investors.

What percentage of Avalo Therapeutics stock is owned by institutional investors?

87.06% of Avalo Therapeutics stock is owned by institutional investors. Learn more on AVTX's institutional investor holdings.

Which institutional investors have been buying Avalo Therapeutics stock?

The following institutional investors have purchased Avalo Therapeutics stock in the last 24 months: Logos Global Management LP ($539.08K), Great Point Partners LLC ($474.64K), Acadian Asset Management LLC ($283.31K), VR Adviser LLC ($250K), Monashee Investment Management LLC ($60K), Ikarian Capital LLC ($46.65K), and Affinity Asset Advisors LLC ($45K).

How much institutional buying is happening at Avalo Therapeutics?

Institutional investors have bought a total of 1,698,672 shares in the last 24 months. This purchase volume represents approximately $262.46M in transactions.

Which Avalo Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Avalo Therapeutics stock in the last 24 months: Armistice Capital LLC ($43.61M), Nantahala Capital Management LLC ($6.17M), Point72 Asset Management L.P. ($5.51M), and Natixis ($2.09K).

How much institutional selling is happening at Avalo Therapeutics?

Institutional investors have sold a total of 55,291,199 shares in the last 24 months. This volume of shares sold represents approximately $44.06B in transactions.



This page (NASDAQ:AVTX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners